Voraxaze Approved to Treat High Levels of Chemo Drug
First Test Approved to Help Detect Risk of Rare Brain Infection
WEDNESDAY, Jan. 18 (Healthday News) -- Voraxaze (glucarpidase) has been approved by the U.S. Food And Drug Administration to treat high blood levels of methotrexate, a common chemotherapy drug. read more..
source:http://yhoo.it/wNvK7J
First Test Approved to Help Detect Risk of Rare Brain Infection
FRIDAY, Jan. 20 (Healthday News) -- The first test to help determine the risk of a rare brain infection among users of the drug Tysabri has been approved by the U.S. Food And Drug Administration. read more..
source:http://yhoo.it/zE2Fkp
No comments:
Post a Comment